Korsana Biosciences, Inc. (KRSA) vs Stoke Therapeutics, Inc. (STOK)
- Korsana Biosciences, Inc. KRSA 32.38 −3.77%
- Stoke Therapeutics, Inc. STOK 24.17 −1.79%
Korsana Biosciences, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Korsana Biosciences, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.6B and $1.5B). Korsana Biosciences, Inc. grew revenue faster over the last twelve months: 30.8% against −86.2%. Korsana Biosciences, Inc. has the higher net margin (0.00% vs −753.6%) and the higher return on invested capital (−115.4% vs −264.8%). Across the 15 metrics below, Korsana Biosciences, Inc. leads on 9 and Stoke Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | KRSA | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (809.69%) | 0.00% |
| Net margin | 0.00% | (753.60%) | 0.00% |
| Free cash flow margin | 0.00% | (654.92%) | 0.00% |
| Return on equity | (98.22%) | (61.10%) | (56.36%) |
| Return on assets | (82.29%) | (53.41%) | (48.04%) |
| Return on invested capital | (115.40%) | (264.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack